COVID-19 Impact on Global Long Acting Insulins Market Size, Status and Forecast 2020-2026

August 2020 | 93 pages | ID: C4FF267BBF92EN
QYResearch

Abstracts

This report focuses on the global Long Acting Insulins status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Long Acting Insulins development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Novo Nordisk
• Sanofi
• Wockhardt UK

Market segment by Type, the product can be split into

• Insulin Glargine
• Insulin Determir
• Insulin Degludec
• Long Acting Animal Insulin

Market segment by Application, split into

• Home Use
• Medical Institutions
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Long Acting Insulins status, future forecast, growth opportunity, key market and key players.
• To present the Long Acting Insulins development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Long Acting Insulins are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Long Acting Insulins Revenue
1.4 Market Analysis by Type
  1.4.1 Global Long Acting Insulins Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Insulin Glargine
  1.4.3 Insulin Determir
  1.4.4 Insulin Degludec
  1.4.5 Long Acting Animal Insulin
1.5 Market by Application
  1.5.1 Global Long Acting Insulins Market Share by Application: 2020 VS 2026
  1.5.2 Home Use
  1.5.3 Medical Institutions
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Long Acting Insulins Industry Impact
  1.6.1 How the Covid-19 is Affecting the Long Acting Insulins Industry
    1.6.1.1 Long Acting Insulins Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Long Acting Insulins Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Long Acting Insulins Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Long Acting Insulins Market Perspective (2015-2026)
2.2 Long Acting Insulins Growth Trends by Regions
  2.2.1 Long Acting Insulins Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Long Acting Insulins Historic Market Share by Regions (2015-2020)
  2.2.3 Long Acting Insulins Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Long Acting Insulins Market Growth Strategy
  2.3.6 Primary Interviews with Key Long Acting Insulins Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Long Acting Insulins Players by Market Size
  3.1.1 Global Top Long Acting Insulins Players by Revenue (2015-2020)
  3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2015-2020)
  3.1.3 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Long Acting Insulins Market Concentration Ratio
  3.2.1 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Long Acting Insulins Revenue in 2019
3.3 Long Acting Insulins Key Players Head office and Area Served
3.4 Key Players Long Acting Insulins Product Solution and Service
3.5 Date of Enter into Long Acting Insulins Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Long Acting Insulins Historic Market Size by Type (2015-2020)
4.2 Global Long Acting Insulins Forecasted Market Size by Type (2021-2026)

5 LONG ACTING INSULINS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Long Acting Insulins Market Size by Application (2015-2020)
5.2 Global Long Acting Insulins Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Long Acting Insulins Market Size (2015-2020)
6.2 Long Acting Insulins Key Players in North America (2019-2020)
6.3 North America Long Acting Insulins Market Size by Type (2015-2020)
6.4 North America Long Acting Insulins Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Long Acting Insulins Market Size (2015-2020)
7.2 Long Acting Insulins Key Players in Europe (2019-2020)
7.3 Europe Long Acting Insulins Market Size by Type (2015-2020)
7.4 Europe Long Acting Insulins Market Size by Application (2015-2020)

8 CHINA

8.1 China Long Acting Insulins Market Size (2015-2020)
8.2 Long Acting Insulins Key Players in China (2019-2020)
8.3 China Long Acting Insulins Market Size by Type (2015-2020)
8.4 China Long Acting Insulins Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Long Acting Insulins Market Size (2015-2020)
9.2 Long Acting Insulins Key Players in Japan (2019-2020)
9.3 Japan Long Acting Insulins Market Size by Type (2015-2020)
9.4 Japan Long Acting Insulins Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Long Acting Insulins Market Size (2015-2020)
10.2 Long Acting Insulins Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Long Acting Insulins Market Size by Type (2015-2020)
10.4 Southeast Asia Long Acting Insulins Market Size by Application (2015-2020)

11 INDIA

11.1 India Long Acting Insulins Market Size (2015-2020)
11.2 Long Acting Insulins Key Players in India (2019-2020)
11.3 India Long Acting Insulins Market Size by Type (2015-2020)
11.4 India Long Acting Insulins Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Long Acting Insulins Market Size (2015-2020)
12.2 Long Acting Insulins Key Players in Central & South America (2019-2020)
12.3 Central & South America Long Acting Insulins Market Size by Type (2015-2020)
12.4 Central & South America Long Acting Insulins Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Details
  13.1.2 Novo Nordisk Business Overview and Its Total Revenue
  13.1.3 Novo Nordisk Long Acting Insulins Introduction
  13.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2015-2020))
  13.1.5 Novo Nordisk Recent Development
13.2 Sanofi
  13.2.1 Sanofi Company Details
  13.2.2 Sanofi Business Overview and Its Total Revenue
  13.2.3 Sanofi Long Acting Insulins Introduction
  13.2.4 Sanofi Revenue in Long Acting Insulins Business (2015-2020)
  13.2.5 Sanofi Recent Development
13.3 Wockhardt UK
  13.3.1 Wockhardt UK Company Details
  13.3.2 Wockhardt UK Business Overview and Its Total Revenue
  13.3.3 Wockhardt UK Long Acting Insulins Introduction
  13.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2015-2020)
  13.3.5 Wockhardt UK Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Long Acting Insulins Key Market Segments
Table 2. Key Players Covered: Ranking by Long Acting Insulins Revenue
Table 3. Ranking of Global Top Long Acting Insulins Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Long Acting Insulins Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Insulin Glargine
Table 6. Key Players of Insulin Determir
Table 7. Key Players of Insulin Degludec
Table 8. Key Players of Long Acting Animal Insulin
Table 9. COVID-19 Impact Global Market: (Four Long Acting Insulins Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Long Acting Insulins Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Long Acting Insulins Players to Combat Covid-19 Impact
Table 14. Global Long Acting Insulins Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Long Acting Insulins Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Long Acting Insulins Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Long Acting Insulins Market Share by Regions (2015-2020)
Table 18. Global Long Acting Insulins Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Long Acting Insulins Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Long Acting Insulins Market Growth Strategy
Table 24. Main Points Interviewed from Key Long Acting Insulins Players
Table 25. Global Long Acting Insulins Revenue by Players (2015-2020) (Million US$)
Table 26. Global Long Acting Insulins Market Share by Players (2015-2020)
Table 27. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long Acting Insulins as of 2019)
Table 28. Global Long Acting Insulins by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Long Acting Insulins Product Solution and Service
Table 31. Date of Enter into Long Acting Insulins Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 34. Global Long Acting Insulins Market Size Share by Type (2015-2020)
Table 35. Global Long Acting Insulins Revenue Market Share by Type (2021-2026)
Table 36. Global Long Acting Insulins Market Size Share by Application (2015-2020)
Table 37. Global Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 38. Global Long Acting Insulins Market Size Share by Application (2021-2026)
Table 39. North America Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Long Acting Insulins Market Share (2019-2020)
Table 41. North America Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 42. North America Long Acting Insulins Market Share by Type (2015-2020)
Table 43. North America Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 44. North America Long Acting Insulins Market Share by Application (2015-2020)
Table 45. Europe Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Long Acting Insulins Market Share (2019-2020)
Table 47. Europe Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Long Acting Insulins Market Share by Type (2015-2020)
Table 49. Europe Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Long Acting Insulins Market Share by Application (2015-2020)
Table 51. China Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 52. China Key Players Long Acting Insulins Market Share (2019-2020)
Table 53. China Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 54. China Long Acting Insulins Market Share by Type (2015-2020)
Table 55. China Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 56. China Long Acting Insulins Market Share by Application (2015-2020)
Table 57. Japan Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Long Acting Insulins Market Share (2019-2020)
Table 59. Japan Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Long Acting Insulins Market Share by Type (2015-2020)
Table 61. Japan Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Long Acting Insulins Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Long Acting Insulins Market Share (2019-2020)
Table 65. Southeast Asia Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Long Acting Insulins Market Share by Type (2015-2020)
Table 67. Southeast Asia Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Long Acting Insulins Market Share by Application (2015-2020)
Table 69. India Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 70. India Key Players Long Acting Insulins Market Share (2019-2020)
Table 71. India Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 72. India Long Acting Insulins Market Share by Type (2015-2020)
Table 73. India Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 74. India Long Acting Insulins Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Long Acting Insulins Market Share (2019-2020)
Table 77. Central & South America Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Long Acting Insulins Market Share by Type (2015-2020)
Table 79. Central & South America Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Long Acting Insulins Market Share by Application (2015-2020)
Table 81. Novo Nordisk Company Details
Table 82. Novo Nordisk Business Overview
Table 83. Novo Nordisk Product
Table 84. Novo Nordisk Revenue in Long Acting Insulins Business (2015-2020) (Million US$)
Table 85. Novo Nordisk Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Product
Table 89. Sanofi Revenue in Long Acting Insulins Business (2015-2020) (Million US$)
Table 90. Sanofi Recent Development
Table 91. Wockhardt UK Company Details
Table 92. Wockhardt UK Business Overview
Table 93. Wockhardt UK Product
Table 94. Wockhardt UK Revenue in Long Acting Insulins Business (2015-2020) (Million US$)
Table 95. Wockhardt UK Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Long Acting Insulins Market Share by Type: 2020 VS 2026
Figure 2. Insulin Glargine Features
Figure 3. Insulin Determir Features
Figure 4. Insulin Degludec Features
Figure 5. Long Acting Animal Insulin Features
Figure 6. Global Long Acting Insulins Market Share by Application: 2020 VS 2026
Figure 7. Home Use Case Studies
Figure 8. Medical Institutions Case Studies
Figure 9. Others Case Studies
Figure 10. Long Acting Insulins Report Years Considered
Figure 11. Global Long Acting Insulins Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Long Acting Insulins Market Share by Regions: 2020 VS 2026
Figure 13. Global Long Acting Insulins Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Long Acting Insulins Market Share by Players in 2019
Figure 16. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long Acting Insulins as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Long Acting Insulins Revenue in 2019
Figure 18. North America Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2015-2020)
Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2015-2020)
Figure 29. Wockhardt UK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2015-2020)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed